Stay updated on Galegenimab in Geographic Atrophy AMD: Clinical Trial

Sign up to get notified when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galegenimab in Geographic Atrophy AMD: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. This appears to be a backend version update with no visible changes to study content or page layout.
    Difference
    0.0%
    Check dated 2025-12-01T17:28:31.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.1, replacing the previous Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T14:43:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Deleted the funding/operating status notice related to government funding. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:56:10.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Results have been posted for the GALLEGO study (Results First Posted 2024-03-27). The study status is Terminated due to an unfavorable benefit–risk balance.
    Difference
    0.3%
    Check dated 2025-11-03T01:21:39.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    3%
    Check dated 2025-10-05T10:07:33.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:14:43.000Z thumbnail image

Stay in the know with updates to Galegenimab in Geographic Atrophy AMD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.